ArticleEuropean geriatric medicine2026
Prognostic performance of Asian Working Group for Sarcopenia 2025 Constructs for activities of daily living at discharge after stroke: a head-to-head validation.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the prognostic performance of the Asian Working Group for Sarcopenia (AWGS) 2025 diagnostic constructs-specifically height- versus body mass index (BMI)-indexed muscle mass-for discriminating functional outcomes in patients with stroke.
methodsFrom a cohort of 1246 consecutive post-acute stroke admissions, we analyzed 864 inpatients (median age 76 years; 47.2% women) who met the inclusion criteria. Sarcopenia was classified according to AWGS 2025 criteria: possible sarcopenia (low handgrip strength) and confirmed sarcopenia (low strength plus low skeletal muscle mass). Skeletal muscle mass was indexed by height-squared (SMI/height2) and BMI (SMI/BMI). Multivariable linear regression analysis, stratified by age (50-64 vs. ≥ 65 years) and sex, assessed the associations with the Functional Independence Measure motor subscale (FIM-motor) at discharge.
resultsConfirmed sarcopenia defined by SMI/height
conclusionAWGS 2025 confirmed sarcopenia utilizing height-indexed muscle mass provided superior prognostic discrimination for discharge ADL compared with BMI-indexed or possible sarcopenia constructs in post-stroke inpatients. These findings support prioritizing height-indexed confirmed sarcopenia for functional risk stratification in this setting.
Indexed as
Identifiers
42412390What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.